Page last updated: 2024-09-04

ampelopsin and methylnitrosourea

ampelopsin has been researched along with methylnitrosourea in 1 studies

Compound Research Comparison

Studies
(ampelopsin)
Trials
(ampelopsin)
Recent Studies (post-2010)
(ampelopsin)
Studies
(methylnitrosourea)
Trials
(methylnitrosourea)
Recent Studies (post-2010) (methylnitrosourea)
37723433,24210346

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, Q; Chang, H; Mi, M; Peng, X; Yu, X; Zhang, Q; Zhou, Y; Zhu, J1

Other Studies

1 other study(ies) available for ampelopsin and methylnitrosourea

ArticleYear
Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway.
    Carcinogenesis, 2014, Volume: 35, Issue:8

    Topics: Alkylating Agents; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Female; Flavonoids; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoprecipitation; Methylnitrosourea; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014